Midkine Gene Promoter Activates Suicide Gene in Liver Cancer
Author Information
Author(s): Tomizawa M, Yu L, Wada A, Tamaoki T, Kadomatsu K, Muramatsu T, Matsubara S, Watanabe K, Ebara M, Saisho H, Sakiyama S, Tagawa M
Primary Institution: Chiba Cancer Center
Hypothesis
Can the midkine gene promoter activate a suicide gene as effectively as the α-fetoprotein promoter in hepatocellular carcinoma?
Conclusion
The midkine promoter can activate a suicide gene in liver cancer cells as effectively as the α-fetoprotein promoter.
Supporting Evidence
- 14 out of 15 HCC specimens expressed MK mRNA, while only 3 expressed AFP.
- The transcriptional activity of the MK promoter was comparable to that of the enhancer-linked AFP promoter.
- MK promoter-based therapy could selectively kill HCC cells without harming surrounding tissues.
Takeaway
This study found that a gene called midkine can help kill liver cancer cells when used in a special way, just like another gene called α-fetoprotein.
Methodology
The study used Northern blot analysis and dual luciferase assays to compare the expression and activity of midkine and α-fetoprotein promoters in liver cancer cells.
Potential Biases
Potential bias in sample selection from a single cancer center.
Limitations
The study's findings may not apply to all liver cancer cases due to variability in gene expression.
Participant Demographics
Patients with hepatocellular carcinoma, including both male and female participants aged 23 to 74.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website